SCHEMBL31363348

SCHEMBL31363348

C#CCNc1ccc(S(C)(=O)=O)cc1C(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 1/20 0.34
▸ ALDH3A1 P30838 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MAOA P21397 2/20 0.33
▸ MAOB P27338 2/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ PDK1 Q15118 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PDK3 Q15120 1/20 0.33
▸ PDK4 Q16654 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30871243 0.81 CA1 (0.44) CA12CA1CA2CA9ALDH3A1
SCHEMBL29812039 0.79 CA12 (0.49) CA12CA1CA2CA9ALDH1A1
SCHEMBL23143891 0.79 CA12 (0.49) CA12CA1CA2CA9ALDH1A1
SCHEMBL23144126 0.79 CA12 (0.45) CA12CA1CA2CA9ALDH1A1
SCHEMBL23144768 0.79 CA12 (0.40) CA12CA1CA2CA9ALDH1A1
SCHEMBL23144110 0.78 PDK1 (0.46) CA12CA1CA2CA9ALDH1A1
SCHEMBL25032911 0.78 LRRK2 (0.37) CA12CA1CA2CA9ALDH1A1
SCHEMBL23143977 0.77 LRRK2 (0.42) CA12CA1CA2CA9ALDH1A1
SCHEMBL23144748 0.75 TOP2B (0.48) CA12CA1CA2CA9ALDH1A1
SCHEMBL29212406 0.75 CA12 (0.42) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059074-A1 BICYCLIC COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2025-03-20 — — WO disclosed
Send feedback